List of partners

The following companies and organisations have confirmed their participation in the 32nd ECNP Congress.

In alphabetical order:

ANGELINI
Stand number: 3
Satellite symposium: C.11

Angelini Pharma is an international company with branches in 18 countries and worldwide product distribution. The area of CNS-acting drugs is the field where Angelini has achieved a great success and recognition at world level. The RR&D is steadily searching and developing new solutions in the area of CNS.
www.angelini.it

  Angelini

Brazilian Association of Psychiatry (ABP)
Stand number: 15

Brazilian Association of Psychiatry – ABP is a Civil Association of a scientific nature, non-profit, with the objective of gathering psychiatrists and to defend those who suffer from Mental Disorder. The ABP annually holds the Brazilian Congress of Psychiatry.
www.abp.org.br



ABP
ECHO (European Consortium for Observational Studies on Mental Health Products)
Stand number: 13

ECHO (European Consortium for Observational Studies on Mental Health Products) offers a unique package for conducting PASS (post-authorisation safety studies) and other observational studies on mental health products. ECHO combines the Drug Safety Research Unit’s pharmacovigilance and pharmacoepidemiological expertise, with an experienced team of mental health specialists from across Europe.
www.dsru.org/service/mental-health-products-echo-capabilities

  ECHO (European Consortium for Observational Studies on Mental Health Products) 
EUFAMI
Stand number: 21

EUFAMI is an international NGO based in Belgium committed to improving the care for and welfare of people with mental ill health. Our mission is to represent at the European level all family members of persons affected by mental ill health and to protect their rights and interests.
www.eufami.org

  EUFAMI
European Brain Council (EBC)
Stand number: 22
The European Brain Council is a network of key players in the 'brain area', with a membership encompassing scientific societies, patient organisations, professional societies and industry partners. Its main mission is to promote brain research with the ultimate goal of improving the lives of the estimated 179 million Europeans living with brain conditions.
www.braincouncil.eu

   EBC
European Psychiatric Association (EPA)
Stand number: 16

With active individual members in 88 countries and 44 National Society Association Members who represent more than 80,000 European psychiatrists, the European Psychiatric Association is the main association representing psychiatry in Europe. EPA’s activities address the interests of psychiatrists in academia, research and practice throughout all stages of career development.
www.europsy.net

   EPA
Femtonics Ltd.
Stand number: 17

Femtonics’ flagship multiphoton microscope - Femto3D Atlas - implements and goes beyond the traditional imaging functions and combines them with ultimate 3D imaging feature, providing all-in-one solution. With 3D Atlas scope researchers are able to scan neuronal, dendritic and other neuropil activities in a near mm3 volume with astonishing speed.
www.femtonics.eu

  Femtonics Ltd. 
FENS
Stand number: 14

Founded in 1998 at the first Forum of Neuroscience, the Federation of European Neuroscience Societies (FENS) is the main organisation for neuroscience in Europe. FENS currently represents 43 European national and single discipline neuroscience societies with close to 24,000 member scientists from 33 European countries.
www.fens.org

   FENS
Frontiers
Stand number: 25

Frontiers is an award-winning Open Science platform and leading Open Access scholarly publisher. Our mission is to make high-quality, peer-reviewed research articles rapidly and freely available to everybody in the world, thereby accelerating scientific and technological innovation, societal progress and economic growth.
https://frontiersin.org

  frontiers 
GAMIAN-Europe
Stand number: 20

Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) is a patient-driven pan-European organisation, representing the interests of persons affected by mental illness and advocates for their rights. Our main objectives are: advocacy, information and education, anti-stigma and discrimination, patients’ rights, co-operation, partnerships and capacity building.
www.gamian.eu

  GAMIAN-Europe  
Gedeon Richter Plc
Stand number: 7
Satellite symposium: C.09


Headquartered in Hungary, Gedeon Richter is an innovation-driven specialty pharmaceutical company. With 1000-strong R&D team the company boasts the biggest pharmaceutical research centre in CEU. Its latest achievement is the original antipsychotic compound, cariprazine, already marketed in the US for bipolar mania and schizophrenia treatment and received marketing authorization in the EU for the treatment of schizophrenia in adult patients and has been marketed in the majority of EU countries.
www.richter.hu

   gedeon-richter
H. Lundbeck A/S
Stand number: 2 & 4
Satellite symposium: C.03, C.07 and C.10
Expert Science Exchange session: CE.02
Innovation Showcase session: IN.02
Industry Views

Lundbeck is a global pharmaceutical company specialized in discovering and developing innovative treatments for people living with brain diseases. We are tirelessly dedicated to restoring brain health, so every person can be their best.
www.lundbeck.com #brainhealth #progressinmind

  Lundbeck 
JAMA Network
Stand number: 23

Building on a tradition of editorial excellence, the JAMA Network brings JAMA together with eleven specialty journals to offer enhanced access to the research, viewpoints, and opinions shaping the future of medicine. JAMA Network Open, a new open access, general medical journal launched in 2018.
www.jamanetwork.com

   JAMA Network
Janssen Cilag LTD
Stand number: 5

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.

Learn more at www.janssen.com. Follow us at www.twitter.com/JanssenGlobal. Janssen Pharmaceutica N.V is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
www.janssen.com

  Janssen
Janssen EMEA
Stand number: 1

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science.
www.janssen.com/emea

  Janssen 
Janssen Pharmaceutica NV
Stand number: 6
Satellite symposia: C.04 and C.12


At Janssen, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We collaborate with the world for the health of everyone in it. Follow us at www.twitter.com/janssenEMEA
www.janssen.com

  Janssen 
MEDICE Arzneimittel Pütter GmbH & Co. KG
Stand number: 10
Expert Science Exchange session: CE.01


MEDICE is one of the most successful family-owned pharmaceutical companies in Germany. Committed to the fundamental ethical values of medicine, MEDICE has been demonstrating for almost 70 years that humanity and confidence are a strong basis for innovation and growth.
www.medice.de

  MEDICE Arzneimittel Pütter GmbH & Co. KG 
Medscape Psychiatry
(unrestricted grant from H. Lundbeck A/S)

Satellite symposium: C.06

Medscape Education delivers a fresh approach to live events with interactive and engaging sessions expertly produced by Medscape Studios. Dynamic experts facilitate learning and discussion on timely clinical topics, and innovative and unique session formats drive engagement and elevate the opportunities for live education.
www.medscape.org/psychiatry

  Medscape Psychiatry  
Neuroscience-based Nomenclature (NbN)
Stand number: 18

The Neuroscience-based Nomenclature (NbN) is an ECNP-led international collaboration established to align the nomenclature of psychotropic drugs with the neuroscience underlying them. The new nomenclature encompasses all medications with CNS indications and is now available to clinicians for free download on the iOS App Store and the Google Play Store.
http://nbnomenclature.org

  NBN logo new 2017 
RECORDATI S.p.A
Stand number: 7
Satellite symposium: C.09


Recordati is an international pharmaceutical group, listed on the Italian Stock Exchange, dedicated to the research, development and marketing of pharmaceuticals products. Recordati is committed to the research and development of new specialties in cardiovascular, urological and psychiatric areas with a focus on treatments for rare diseases.
www.recordati.it

  Recordati
Sage Therapeutics, Inc.
Stand number: 8
Expert Science Exchange sessions: CE.03 and CE.04
Innovation Showcase session: IN.01


Sage Therapeutics is committed to discovering and developing life-altering therapies to treat central nervous system (CNS) disorders, and we are dedicated in our pursuit to deliver new medicines with the goal of making life better for patients and their families.
www.sagerx.com

  Sage Therapeutics 
Saladax Biomedical
Stand number: 9

The Saladax MyCare Psychiatry line provides antipsychotic drug levels for greater insight into patient adherence and possible treatment failures. This simple blood test can be performed at point of care or in a laboratory. Saladax believes that truly personalized medicine can only exist when the right drug is taken at the right dose.
www.mycaretests.com

  Saladax Biomedical  
Sanofi
Satellite symposium: C.01

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Sanofi, Empowering Life
www.Sanofi.com

  Sanofi 
SEI Healthcare LLC
Stand number: 11

SEI Healthcare is a global professional Independent Medical Education organization. Our programmes turn cutting edge science into actionable insights that improve clinical decisions and patient outcomes. Our mission is to organise the world’s medical information and make it universally accessible & useful.
www.sei-healthcare.com

  SEI Healthcare LLC 
Shire Denmark A/S, part of the Takeda group
Stand number: 12

Takeda is a global, research & development-driven pharmaceutical leader headquartered in Japan. We focuse our efforts on four therapeutic areas: Oncology, Gastroenterology, Neuroscience and Rare Diseases. Our employees are committed to improving quality of life for patients and to working with our partners in health care in 80 countries.
www.takeda.com

  Shire Denmark - Takeda group 
Shire GmbH, a part of the Takeda group
Expert Science Exchange sessions: CE.06 and CE.07

Takeda is a global, research & development-driven pharmaceutical leader headquartered in Japan. We focus our efforts on four therapeutic areas: Oncology, Gastroenterology, Neuroscience and Rare Diseases. Our employees are committed to improving quality of life for patients and to working with our partners in health care in 80 countries.
www.takeda.com

  Shire GmbH-Takeda group 
Shire part of Takeda/Global Medical Education
Satellite symposium: C.02

Global Medical Education (GME) is a continuing medical education company, focusing primarily on psychiatry, that offers free, timely, unbiased, evidence-based information from the world’s leading experts to clinicians around the world.
www.gmeded.com

  Global Medical Education 
Sunovion Pharmaceuticals Europe
Stand number: 3

At Sunovion Pharmaceuticals Europe Ltd., we focus on the introduction and commercialisation of innovative medicines that improve people's lives, with a current specialisation in mental health. Sunovion Pharmaceuticals Europe, headquartered in London, is a wholly owned subsidiary of Sunovion Pharmaceuticals Inc.
www.sunovion.eu

  Sunovion
Sunovion Pharmaceuticals Inc.
Satellite symposium: C.11

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. With patients at the center of everything it does, Sunovion has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. Headquartered in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc.
Additional information can be found on the company’s websites: www.sunovion.com, www.sunovion.eu and www.sunovion.ca.
 
  Sunovion 

Sumitimo Dainippon Pharma Co. Ltd.
Satellite symposium: C.11

Sumitomo Dainippon Pharma is among the top-ten listed pharmaceutical companies in Japan, operating globally in major pharmaceutical markets, including Japan, the U.S., China and the European Union. Sumitomo Dainippon Pharma aims to create innovative pharmaceutical products in the Psychiatry & Neurology area, the Oncology area and Regenerative medicine/Cell therapy field, which have been designated as the focus therapeutic areas. Today Sumitomo Dainippon Pharma has more than 6,000 employees worldwide.
www.ds-pharma.com

  Sumitomo 
Upjohn, A Pfizer Division
Expert Science Exchange session: CE.05
Industry Views

At Upjohn, our mission is relieving the burden of NCDs with trusted, quality medicines for every patient, everywhere.
https://www.pfizer.com/products/upjohn

  Upjohn-Pfizer 

The International College of Neuropsychopharmacology (CINP)
Stand number: 26

The International College of Neuropsychopharmacology (CINP) hold regular meetings in the form of Training, Educational Programs, International Meetings, and World Congresses, CINP reaches interested researchers all over the world. Clinicians hear about the latest research advances and new treatments whilst researchers hear about new clinical needs and problems.
www.cinp.org

  The International College of Neuropsychopharmacology (CINP) 
Transmedica A/S
Stand number: 27

Transmedica is a Danish company founded by doctor Karsten Ramsløv Svendsen in 1990. For much the same reason, Transmedica is a well-known name in the industry. We're working with temporary jobs for specialist doctors and nurses in the Scandinavian countries such as Norway, Sweden and Denmark.
www.transmedica.dk
 
  Transmedica A/S 
Wisepress Medical Bookshop
Stand number: 24

Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide.
www.wisepress.com

  Wisepress